Core Viewpoint - Hengwei Group Holdings (08219) reported a mid-year performance for 2025, showing a revenue of approximately HKD 54.06 million, which represents an increase of about 4.34% compared to the same period in 2024 [1] Financial Performance - The company recorded a profit attributable to shareholders of approximately HKD 1.06 million, marking a turnaround from a loss in the previous year [1] - Basic earnings per share were approximately HKD 0.43 cents [1]

Core Viewpoint - Hengwei Group Holdings (08219) reported a mid-year performance for 2025, showing a revenue of approximately HKD 54.06 million, which represents an increase of about 4.34% compared to the same period in 2024 [1] Financial Performance - The profit attributable to the company's owners was approximately HKD 1.06 million, marking a turnaround from a loss to a profit year-on-year [1] - Basic earnings per share were approximately HKD 0.43 cents [1]

Group 1 - The company Zhejiang Shibao (01057) reported a mid-year performance for 2025, with operating revenue of approximately 1.524 billion yuan, representing a year-on-year increase of 35.32% [1] - The net profit attributable to shareholders of the listed company was approximately 93.0344 million yuan, reflecting a year-on-year growth of 39.09% [1] - The basic earnings per share were reported at 0.1131 yuan [1]

Core Viewpoint - 中核国际 (02302) reported a significant increase in revenue and a turnaround in profit for the six months ending June 30, 2025, primarily driven by a surge in uranium trading activities [1] Financial Performance - Revenue reached HKD 592 million, representing a year-on-year increase of 9151.72% [1] - Shareholders' profit amounted to HKD 10.359 million, compared to a loss of HKD 7.731 million in the same period last year, indicating a successful turnaround [1] - Basic earnings per share were HKD 0.0212 [1] Business Operations - The substantial revenue growth was mainly attributed to a significant increase in the trading volume of uranium, with approximately HKD 582 million of revenue generated from transactions involving natural uranium sold to independent third parties [1]

Core Viewpoint - Hengxin Technology (01085) reported a decline in revenue and a significant loss for the first half of 2025, primarily due to decreased income from its wireless communication segment [1] Financial Performance - The company achieved revenue of RMB 1.022 billion for the six months ending June 30, 2025, representing a year-on-year decrease of 8.35% [1] - The loss attributable to equity shareholders was RMB 70.42 million, compared to a profit of RMB 26.589 million in the same period last year [1] - Basic loss per share was RMB 0.152 [1] Segment Performance - Revenue from the wireless communication segment was approximately RMB 854 million in the first half of 2025, down about RMB 115 million or 11.9% from approximately RMB 969 million in the first half of 2024 [1]

Core Insights - The company reported a revenue of approximately 669 million, representing a year-on-year decrease of 21.3% [1] - Gross profit was about 105 million, down 50.3% year-on-year [1] - Net profit was 60.93 million, marking a turnaround from a loss to profit [1] - Earnings per share stood at 0.08 [1] Revenue and Profit Analysis - The decline in revenue is primarily attributed to intensified competition leading to a decrease in project unit prices [1] - The increase in net profit is mainly due to changes in the fair value of biological assets [1] - The company recognized a gain of 95 million from the fair value changes of biological assets during the period [1] Biological Assets Performance - For the six months ending June 30, 2025, the gains from biological assets were driven by natural growth [1] - In contrast, for the six months ending June 30, 2024, the company reported a loss of 254.4 million, primarily due to a decrease in the unit fair value of biological assets, consistent with the decline in market prices of experimental models [1]

Core Viewpoint - Yili International (00585) reported a significant decline in total revenue for the six months ending June 30, 2025, amounting to HKD 10.18 million, representing a year-on-year decrease of 61.78% [1] Financial Performance - The company achieved a profit attributable to shareholders of HKD 5.375 million, a turnaround from a loss of HKD 11.459 million in the same period last year, indicating a successful recovery [1] - Basic earnings per share were reported at HKD 0.65 [1]

本期度毛利减至4.54亿港元，而去年同期为5.27亿港元。该减少主要由于若干项目将近完工，而新投得 项目仍处于初期阶段，尚未产生显著贡献。然而，行政费用、其他亏损及摊占合营企业的亏损减少已降 低毛利减少的影响。 利基控股(00240)发布截至2025年6月30日止6个月中期业绩，该集团取得服务收入68.998亿港元，同比增 加6.6%;公司拥有人应占溢利1.79亿港元，同比增加20.49%;每股盈利14.4港仙，拟派发中期股息每股4港 仙。 ...

大方广瑞德(00755)发布截至2025年6月30日止6个月业绩，该集团期内取得收入5143.4万港元，同比减少 49.96%;公司拥有人应占亏损1638.9万港元，同比收窄97.03%;每股基本亏损0.1港元。 ...

【#绿城中国中期净利暴跌90%#，"换帅"后#绿城中国创下19年来最低中期净利#】 近日，绿城中国（03900.HK）公告了2025年中期业绩，这是中交系老将刘成云空降接任董事会主席后 交出的首份"成绩单"。 这份中期业绩报告显示，绿城中国的期内营收、毛利双双下滑，公司股东应占净利润仅为2.1亿元，相 比去年同期的20.45亿元，跌近90%。 2.1亿元的数据，创下绿城中国自2006年在港交所上市以来最低中期净利润纪录。 绿城中国上市首年，即2006年，绿城中期收入为12.10亿元，公司股东应占净利为2.57亿元。如今，绿城 的半年度营收是当年的40多倍，但净利润还不如19年前。 ...